PURAPHARM CORPORATION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.75 HKD | +1.35% |
|
-1.32% | -16.67% |
| Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
| Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 37.31M | |
| +37.15% | 6.01B | |
| -16.04% | 4.47B | |
| -11.16% | 3.11B | |
| -1.40% | 3.01B | |
| +0.12% | 2.6B | |
| +38.69% | 1.85B | |
| +1.11% | 1.66B | |
| -10.34% | 1.63B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- 1498 Stock
- News PuraPharm Corporation Limited
- Purapharm : Cancels Sale of Intellectual Property Assets to BAGI Research
